Search Results - Melissa Accordino

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Cardiac Effects of Anticancer Therapy in the Elderly

    Cardiac Effects of Anticancer Therapy in the Elderly by Melissa Accordino, Alfred I. Neugut, Dawn L. Hershman

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City

    Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City by Kevin Kalinsky, Melissa Accordino, Kristina Hosi, Jessica E. Hawley, Meghna S. Trivedi, Katherine D. Crew, Dawn L. Hershman

    Published 2020
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data

    FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data by Alfred I. Neugut, Aijing Lin, Gabriel Raab, Grace Clarke Hillyer, Deborah S. Keller, Daniel S. O’Neil, Melissa Accordino, Ravi P. Kiran, Jason D. Wright, Dawn L. Hershman

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

    Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update by Andrea Eisen, Mark R. Somerfield, Melissa Accordino, Phillip S. Blanchette, Mark Clemons, Sukhbinder Dhesy‐Thind, Melissa S. Dillmon, Stella D’Oronzo, Glenn G. Fletcher, Elizabeth Frank, Sigrun Hallmeyer, Issam Makhoul, Beverly Moy, Alia Thawer, Joy Y. Wu, Catherine Van Poznak

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

    Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer by Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J. Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S. Trivedi, Melissa Accordino, Katherine D. Crew, Dawn L. Hershman, Matthew Maurer, Simon Jones, Anthony A. High, Junmin Peng, Andrea Califano, Kevin Kalinsky, Jiyang Yu, Jose Silva

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

    Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Can... by Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes, Clara Hwang, Sunny Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O’Connor, Trisha M. Wise‐Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Fares Yared, Míriam Santos Dutra, Na Tosha Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan A. Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa Accordino, Harpreet Singh, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, Jeremy L. Warner

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: